We read with great interest the study report of Zamani et al. [1] regarding the prevalence of Celiac disease (CD) among patients with Behcet's disease (BD). They screened sera of 288 consecutive patients with BD whereby CD was diagnosed in only 4 (1.3%). BD is an autoimmune disorder, but the underlying pathogenetic mechanism of the disease is not well understood.
To the Editor,
We read with great interest the study report of Zamani et al. [1] regarding the prevalence of Celiac disease (CD) among patients with Behcet's disease (BD). They screened sera of 288 consecutive patients with BD whereby CD was diagnosed in only 4 (1.3%). BD is an autoimmune disorder, but the underlying pathogenetic mechanism of the disease is not well understood.
BD and CD share many clinical presentations such as recurrent aphthous stomatitis and similar gastrointestinal, musculoskeletal and neurological involvements. A recent report has revealed a possible association between CD and BD. In that study, the authors proposed that screening for CD may be useful in patients with BD in order to detect clinically asymptomatic CD patients [2] .
BD is also common in the Turkish population. We screened sera of 73 patients with BD in our clinic and only one of them was diagnosed as CD with anti-endomysial, anti-tissue transglutaminase antibody positivity and appropriate duodenal biopsy findings. To the best of our knowledge, there are only three studies concerning the association of CD with BD in the literature. In the first study [2] , 11 patients with BD were evaluated for CD and one patient was diagnosed with CD. In the second study [3] , 52 BD patients were screened for CD by only serologic studies but four patients were found to be weakly positive. In the third study [1] , 288 patients with BD were screened for CD and four of them were diagnosed with CD. To date, a total of 424 patients with BD were screened for CD and six (1.4%) of them were diagnosed with CD. The estimated prevalence of CD is reported to be approximately 1-2% in Europe and the United States [4] . Thus, there is no data regarding the increasing prevalence of CD among patients with BD as compared to the general population. Although BD and CD diseases share similar clinical presentations, the coexistence of these two diseases seems only a coincidental situation.
In conclusion, we think that CD should be screened among BD patients only if patients have classic symptoms of CD such as abdominal distension, diarrhea, weight loss or in patients who have unexplained anemia, osteoporosis and infertility.
